Trial Profile
Clinical Trials Insight: 700055530
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 22 Nov 2010
Price :
$35
*
At a glance
- Drugs Timbetasin (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 18 Nov 2010 This trial is expected to begin in 2011, according to a RegeneRx media release.
- 20 Apr 2010 New trial record